ELIXIRGEN THERAPEUTICS
LIVE

Serial Number

97150514

Owner

Elixirgen Therapeutics, Inc.

Attorney

Leonard D. Bowersox

First Use Date

Jul 6, 2023

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ELIXIRGEN THERAPEUTICS Trademark

Serial Number: 97150514 • Registration: 7950350

ELIXIRGEN THERAPEUTICS is a trademark filed by Elixirgen Therapeutics, Inc. on December 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Elixirgen Therapeutics, Inc. (38 trademarks)

855 N. Wolfe St., Suite 624
Baltimore, MD 21205

Entity Type: 03

Trademark Details

Filing Date

December 1, 2021

Registration Date

September 16, 2025

First Use Anywhere

July 6, 2023

First Use in Commerce

July 6, 2023

Published for Opposition

January 9, 2024

Goods & Services

Pharmaceutical drugs for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for medicinal purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; preparations of organisms for medical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases

Research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 16, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 16, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 26, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 26, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2025 CRFA
DIVISIONAL PROCESSING COMPLETE
Sep 4, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 4, 2024 AITU
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 21, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 2, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Apr 12, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 12, 2024 AITU
USE AMENDMENT FILED
Mar 22, 2024 IUAF
DIVISIONAL REQUEST RECEIVED
Mar 22, 2024 DRRR
TEAS STATEMENT OF USE RECEIVED
Mar 22, 2024 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Mar 22, 2024 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 5, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 3, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 7, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP